Shaperon

Shaperon CROIC

The Cash Return on Invested Capital (CROIC) of Shaperon (378800.KQ) as of Nov 5, 2026 is -60.24 %. In the previous year, Cash Return on Invested Capital (CROIC) was -108.13 % — a change of -44.29% (higher).

CROIC

-60.24 %

YoY

-44.29%

Last updated:

Cash Return on Invested Capital (CROIC) of Shaperon is 2025 -60.24 % . Cash Return on Invested Capital (CROIC) of Shaperon was 2024 -108.13 % . It decreases by -44.29% higher compared to the previous year.

The Shaperon CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2019
20.49 KRW
Jan 1, 2020
11.28 KRW
Jan 1, 2021
-30.60 KRW
Jan 1, 2022
-27.80 KRW
Jan 1, 2023
-78.66 KRW
Jan 1, 2024
-108.13 KRW
Jan 1, 2025
-60.24 KRW
The Shaperon CROIC history
YEARCROICYoY
-60.24 %-44.29%
-108.13 %+37.47%
-78.66 %+182.97%
-27.80 %-9.15%
-30.60 %-371.19%
11.28 %-44.93%
20.49 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shaperon Stock analysis

What does Shaperon do? Shaperon Inc is a biotechnology company based in Seoul, South Korea, operating within the healthcare sector. The company focuses on the development of pharmaceutical products targeting conditions such as atopic dermatitis, septicemia, and Alzheimer's disease. Shaperon Inc. has a workforce of 40 full-time employees. The company completed its initial public offering (IPO) on October 19, 2022, and is listed under the ticker symbol 378800.KQ with ISIN KR7378800007. Its website is http://shaperon.com/. Shaperon Inc. is engaged in research, development, manufacturing, and commercialization of therapeutic solutions for pneumonia, Alzheimer's disease, and atopic conditions, among other medicines. The company's headquarters are located in Seoul, South Korea. Shaperon Inc. operates as a publicly traded entity following its IPO in 2022, with a focus on advancing treatments for complex medical conditions through biotechnology innovation. Shaperon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shaperon stock

Cash Return on Invested Capital (CROIC) of Shaperon is -60.24 % in 2025.

Cash Return on Invested Capital (CROIC) of Shaperon changed from -108.13 % to -60.24 %, representing a -44.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Shaperon since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Shaperon with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Shaperon

All Key Metrics — Shaperon